Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bleeding: full-pipeline trial registry
7 of 24 indexed Bleeding trials are currently recruiting.
Corpus placement: #686 of 28,707 conditions by registered trial count.
24 US clinical trials · 7 currently recruiting · #686 of 28,707 conditions by registered trial count
Bleeding: 24 US clinical trials tracked, 7 recruiting.
Bleeding is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Boston Scientific Corporation, running 3 of these trials.
Enrollment posture brief
Registry condition bleeding
OPEN 7 | RECR 29% | LATE 6 | EARLY 4 | RANK #686 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Dyspnea (29% recruiting · 24 trials)
Bleeding lists 7 open slots (29% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bleeding on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bleeding is recruiting below its size-band peers.
7 of 24 indexed trials (29.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Bleeding trials is spread across many organizations.
Boston Scientific Corporation accounts for 3 of 24 trials (12.5%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Bleeding enrolment sits around 236 participants.
Median target enrolment is 236 among the 24 trials that report a genuine target (sentinel values excluded). 5 of those (20.8%) plan for fewer than 100 participants.
-
Bleeding research is mostly interventional.
17 interventional and 7 observational studies make up this index (70.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
24 total, page 1 of 1
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Icahn School of Medicine at Mount Sinai
NCT04045665
Quantra Point-of-Care Hemostasis Monitoring
The Cleveland Clinic
NCT06328647
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
Kristen Ban
NCT06657924
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Karolinska Institutet
NCT04598750
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
Northwell Health
NCT07032792
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
Columbia University
NCT06655376
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
Nicoletta C Machin
NCT07083583
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Anne Murray
NCT07224347
CHAMPION-AF Clinical Trial
Boston Scientific Corporation
NCT04394546
Amplatzer Amulet LAAO vs. NOAC
Abbott Medical Devices
NCT04226547
SIMPLAAFY Clinical Trial
Boston Scientific Corporation
NCT06521463
Amulet™ ADVANCE LAA
Abbott Medical Devices
NCT05997446
LEAVE Safe With DOACs
University of Massachusetts, Worcester
NCT04068727
Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
Medical Compression Systems
NCT00358735
Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting
United Health Products
NCT03654560
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
Weill Medical College of Cornell University
NCT05711524
Obsidio™ Conformable Embolic Registry
Boston Scientific Corporation
NCT06170619
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Oregon Health and Science University
NCT02903121
A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects
Portola Pharmaceuticals
NCT03310021
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
Mayo Clinic
NCT02557672
Peri-device Leakage Closure After LAAO
Cardiovascular Center Frankfurt
NCT04590898
A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban
Portola Pharmaceuticals
NCT02220725
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
International Partnership for Microbicides
NCT05041699
Thromboelastography in Non-elective Cesarean Delivery
Stanford University
NCT01514591
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Bleeding records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bleeding trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bleeding page
24 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Bleeding trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boston Scientific Corporation sponsors the most Bleeding trials on record, review their full trial history before evaluating a specific study. See Boston Scientific Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bleeding condition card totals 24 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.